These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 22213350)

  • 1. Phase transformation in thiamine hydrochloride tablets: Influence on tablet microstructure, physical properties, and performance.
    Chakravarty P; Suryanarayanan R; Govindarajan R
    J Pharm Sci; 2012 Apr; 101(4):1410-22. PubMed ID: 22213350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of solution and vapor phase mediated phase transformation in thiamine hydrochloride.
    Chakravarty P; Govindarajan R; Suryanarayanan R
    J Pharm Sci; 2010 Sep; 99(9):3941-52. PubMed ID: 20575002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification, mechanism, and mitigation of active ingredient phase transformation in tablets.
    Thakral NK; Ragoonanan V; Suryanarayanan R
    Mol Pharm; 2013 Aug; 10(8):3128-36. PubMed ID: 23869937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the dehydration behavior of thiamine hydrochloride (vitamin B1) hydrates: part II.
    Chakravarty P; Berendt RT; Munson EJ; Young VG; Govindarajan R; Suryanarayanan R
    J Pharm Sci; 2010 Apr; 99(4):1882-95. PubMed ID: 19824063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphic changes of thiamine hydrochloride during granulation and tableting.
    Wöstheinrich K; Schmidt PC
    Drug Dev Ind Pharm; 2001 Jul; 27(6):481-9. PubMed ID: 11548854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the dehydration behavior of thiamine hydrochloride (vitamin B1) hydrates: part I.
    Chakravarty P; Berendt RT; Munson EJ; Young VG; Govindarajan R; Suryanarayanan R
    J Pharm Sci; 2010 Feb; 99(2):816-27. PubMed ID: 19623540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing-induced phase transitions of theophylline--implications on the dissolution of theophylline tablets.
    Tantry JS; Tank J; Suryanarayanan R
    J Pharm Sci; 2007 May; 96(5):1434-44. PubMed ID: 17455350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of processing-induced phase transformations on the dissolution of theophylline tablets.
    Debnath S; Suryanarayanan R
    AAPS PharmSciTech; 2004 Feb; 5(1):E8. PubMed ID: 15198529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV; Chotai NP; Patel MP
    Pharmazie; 2008 Apr; 63(4):275-81. PubMed ID: 18468386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the pseudo-crystalline transformation from form i to form II of thiamine hydrochloride (vitamin B(1)).
    Masuda K; Ishige T; Yamada H; Fujii K; Uekusa H; Miura K; Yonemochi E; Terada K
    Chem Pharm Bull (Tokyo); 2011; 59(1):57-62. PubMed ID: 21212548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of on-line Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability.
    Hausman DS; Cambron RT; Sakr A
    Int J Pharm; 2005 Aug; 299(1-2):19-33. PubMed ID: 15979262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mercury porosimetry of microcrystalline cellulose tablets: effect of scanning speed and moisture.
    Westermarck S
    Eur J Pharm Biopharm; 2000 Sep; 50(2):319-25. PubMed ID: 10962244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism by Which Magnesium Oxide Suppresses Tablet Hardness Reduction during Storage.
    Sakamoto T; Kachi S; Nakamura S; Miki S; Kitajima H; Yuasa H
    Chem Pharm Bull (Tokyo); 2016; 64(9):1256-61. PubMed ID: 27581629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Process analytical technology: chemometric analysis of Raman and near infra-red spectroscopic data for predicting physical properties of extended release matrix tablets.
    Shah RB; Tawakkul MA; Khan MA
    J Pharm Sci; 2007 May; 96(5):1356-65. PubMed ID: 17455359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols.
    Kuno Y; Kojima M; Ando S; Nakagami H
    J Control Release; 2005 Jun; 105(1-2):16-22. PubMed ID: 15955365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of two dextrose-based directly compressible excipients.
    Olmo IG; Ghaly ES
    Drug Dev Ind Pharm; 1998 Aug; 24(8):771-8. PubMed ID: 9876525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do roll compaction/dry granulation affect the tableting behaviour of inorganic materials? Microhardness of ribbons and mercury porosimetry measurements of tablets.
    Freitag F; Reincke K; Runge J; Grellmann W; Kleinebudde P
    Eur J Pharm Sci; 2004 Jul; 22(4):325-33. PubMed ID: 15196589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of storage condition on properties of MCC II-based pellets with theophylline-monohydrate.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2014 Oct; 88(2):483-91. PubMed ID: 24950003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.